We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. Read more about our Privacy Policy.

I got it!

Event
18 May 2015
Health

Biosimilars

Latest regulatory, clinical, CMC, market access and commercialisation updates to optimise biosimilar development.

Informa's 12th Annual Biosimilars conference will enable you to identify and execute a successful biosimilar development plan through technical case studies and practical advice from leading biosimilar and regulatory players.- Feedback from 4 EU Regulatory Authorities- Benchmark against industry's leading Biosimilar Developers- Feedback from key stakeholders- Market access, business and commercial strategies for Global Biosimilar DevelopmentDedicated workshops:Evening Seminar, Discussion and Dinner: 18th May 2015Feedback from Stakeholders: Facilitating the Acceptance and Increasing the Uptake of BiosimilarsEvening Seminar, Discussion and Dinner: 19th May 2015Biosimilars Regulatory Evening SurgeryPrice: Please see event website: GBP 0Speakers: Niklas Ekman - Finnish Medicines Agency, Member of CHMP | Dr Steffen Gross - Paul-Ehrlich Institut | René Anour - Austrian Medicines and Medical Devices Agency | Steiner Madsen - Norwegian Medicines Agency | Dr Virginia Acha - Amgen | Roman Ivanoy - BIOCAD | Richard Dicicco - Harvest Moon Pharmaceuticals | Dr Paul Calvo - Sterne, Kessler, Goldstein and Fox | Peter Stenico - Sandoz International, Germany

When

18 May 2015 @ 09:00 am

20 May 2015 @ 05:15 pm

Duration: 2 days, 8 hours


Where

Maritim proArte Hotel

Friedrichstra

Germany


Language

English en


Organised by

evvnt (deactivated)